Ticker
TVTXCompany Name
TRAVERE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 379.57M | 2 | $ 189.54M |
3/31/2025 | $ 374.17M | 2.05 | $ 182.46M |
12/31/2024 | $ 416.7M | 2.08 | $ 200.75M |
9/30/2024 | $ 324.74M | 1.71 | $ 190.04M |
6/30/2024 | $ 368.98M | 3.04 | $ 121.27M |
3/31/2024 | $ 481.08M | 2.78 | $ 173.23M |
12/31/2023 | $ 616.77M | 3.47 | $ 177.91M |
9/30/2023 | $ 686.23M | 4.92 | $ 139.43M |
6/30/2023 | $ 542.05M | 3.99 | $ 135.71M |
3/31/2023 | $ 604.9M | 4.63 | $ 130.65M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for TRAVERE THERAPEUTICS INC is calculated as follows: AssetsC [ $ 497.68M ] / LiabilitesC [ $ 75.43M ]
(=) Current Ratio [ 6.6 ]
Minimum
Sep 30, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |